Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival

Garbay, D., Maki, R. G., Blay, J. Y., Isambert, N., Piperno Neumann, S., Blay, C., Zanardi, E., Boudou-Rouquette, P., Bozec, L., Duffaud, F., Bertucci, F., Italiano, A. (July 2013) Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival. Ann Oncol, 24 (7). pp. 1924-30. ISSN 1569-8041 (Electronic)0923-7534 (Linking)

URL: https://www.ncbi.nlm.nih.gov/pubmed/23493135
DOI: 10.1093/annonc/mdt059

Abstract

BACKGROUND: There are no data regarding the management of advanced soft-tissue sarcoma (STS) in elderly patients. PATIENTS AND METHODS: We retrospectively reviewed the charts of patients >/=75 years old diagnosed with metastatic or unresectable STS between 1991 and 2011 in 11 French and American centers. RESULTS: The study included 361 patients. Of these, 223 patients (62%) received systemic therapy, whereas 123 patients (34%) were managed with best supportive care (BSC) only. Patients who received BSC were more likely to be >/=80 years, with performance status (PS) >/= 2, Charlson comorbidity score >/= 10, and metastatic disease. The median progression-free survival of patients treated with systemic therapy was 4 months (95% CI: 2.9-5.1). Thirty-six patients (16%) stopped chemotherapy because of toxicity. Median overall survival (OS) of patients managed with specific therapy was 10.9 months (95% CI: 8.3-13.5) versus 5.3 months (95% CI: 3.6-7.1) for patients managed with BSC (P = 0.001). On multivariate analysis, age >/= 80 years, PS >/= 2, and number of metastatic sites were the only independent factors associated with OS. CONCLUSION: A high proportion of elderly patients with advanced STS were denied chemotherapy. Further efforts are needed to define better the optimal care for fit and unfit elderly patients with STS.

Item Type: Paper
Uncontrolled Keywords: Aged Aged, 80 and over Anthracyclines/*therapeutic use Antineoplastic Agents/*therapeutic use Disease-Free Survival Female Humans Kaplan-Meier Estimate Male Palliative Care Retrospective Studies Sarcoma/*drug therapy/mortality/secondary Soft Tissue Neoplasms/*drug therapy/mortality/pathology Treatment Outcome chemotherapy elderly sarcoma soft-tissue sarcoma
Subjects: diseases & disorders > cancer > prognosis
diseases & disorders > cancer > cancer types > sarcoma
CSHL Authors:
Communities: CSHL labs > Maki lab
Depositing User: Matt Covey
Date: July 2013
Date Deposited: 20 Oct 2016 16:39
Last Modified: 20 Oct 2016 16:39
Related URLs:
URI: http://repository.cshl.edu/id/eprint/33750

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving